Arch Venture Management’s Maze Therapeutics, Inc. Common Stock MAZE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$50.6M Hold
4,120,053
16.91% 3
2025
Q1
$45.4M Buy
+4,120,053
New +$45.4M 22% 2